Search Results - isotype control antibody

Efalizumab Biosimilar, Endotoxin 0.05 EUmg C045P.05 Syd Labs

Efalizumab Biosimilar, Endotoxin 0.05 EU/mg | C045P.05

Efalizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Efalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...

Epratuzumab Biosimilar, Endotoxin 0.05 EUmg C046P.05 Syd Labs

Epratuzumab Biosimilar, Endotoxin 0.05 EU/mg | C046P.05

Epratuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Epratuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...

Brolucizumab Biosimilar C069P.05 Syd Labs

Brolucizumab Biosimilar, Endotoxin 0.05 EU/mg | C069P.05

Brolucizumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Brolucizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...

Ipilimumab Biosimilar, Human IgG4 S228P Mutant C050P.NA Syd Labs

Ipilimumab Biosimilar, Human IgG4 S228P Mutant | C050P.NA

Ipilimumab Biosimilar, N297A Mutant. The research grade Ipilimumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined experimentally...

Obinutuzumab Biosimilar C057P.05 Syd Labs

Obinutuzumab Biosimilar, Endotoxin 0.05 EU/mg | C057P.05

Obinutuzumab Biosimilar, Endotoxin 0.05 EU/mg. The research grade Obinutuzumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype controls are available. Condition of sample preparation and optimal sample dilution should be determined...

Omalizumab Biosimilar C020P.NA Syd Labs

Omalizumab Biosimilar, N297A Mutant | C020P.NA

Omalizumab Biosimilar, N297A Mutant. Omalizumab biosimilar CHO stable cell line is available for licensing to manufacture the omalizumab protein. The research grade omalizumab biosimilar protein is for research use only (RUO). Recombinant human IgG1 isotype...